LONDON (Reuters): Covid-19 vaccines made by Pfizer and AstraZeneca offer high protection of more than 90% against hospitalisation from the Delta coronavirus variant, a new analysis by Public Health England (PHE) showed on Monday (June 14).
Prime Minister Boris Johnson has announced a delay to the lifting of Covid-19 restrictions in England due to the spread of the highly transmissible Delta variant of concern, first identified in India, which is also associated with a higher risk of hospitalisation among the unvaccinated.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
